Advertisement

Pathology of Prostate Cancer

  • Ashish ChandraEmail author
Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

The diagnosis of clinically suspected prostate carcinoma rests on histopathological confirmation [1]. Histologically, prostate carcinoma is a gland-forming cancer, i.e. an adenocarcinoma with origin most commonly in prostatic acini (acinar adenocarcinoma) and less commonly in ducts (ductal adenocarcinoma). Rarely, squamous cell carcinoma, urothelial carcinoma and small cell carcinoma or even sarcomas may arise in the prostate.

References

  1. 1.
    Varma M, Chandra A. ABC of prostate cancer. In: Dasgupta P, Kirby RS, editors. Pathology of prostate cancer. 1st ed. Oxford: Blackwell; 2011.Google Scholar
  2. 2.
    Lindisfarne E, Yamamoto H, Acher P, et al. Transperineal sector biopsies of the prostate—addressing uncertainty. Int J Surg. 2011;9:572.CrossRefGoogle Scholar
  3. 3.
    Vyas L, Acher P, Challacombe BJ, et al. Indications, results and safety profile of transperineal sector biopsies of the prostate: a single centre experience of 634 cases. BJU Int. 2014;114:32–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Sturch P, Duong K, Kinsella J, et al. V62 Multiparametric MRI–US fusion targeted prostate biopsies with Varian brachytherapy software: precision prostate cancer diagnostics. Eur Urol. 2013;12(1):eV62–3.CrossRefGoogle Scholar
  5. 5.
    Eldred-Evans D, Sturch P, Duong K, et al. Multi-parametric MRI—ultrasound fusion targeted biopsies using varian brachytherapy software: a practical solution to deliver targeted biopsies. Int J Surg. 2013;11:593.CrossRefGoogle Scholar
  6. 6.
    Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277:1445–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology. 2001;58:843–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90:766–71.CrossRefPubMedGoogle Scholar
  9. 9.
    Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98:715–7.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999;17:1499–507.CrossRefPubMedGoogle Scholar
  11. 11.
    Zelefsky MJ, Eastham JA, Sartor AO. Cancer of the prostate. In: DeVita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer: principles and practice of oncology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 1220–71.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Cellular Pathology, Guy’s and St Thomas’ Hospitals NHS Foundation TrustLondonUK

Personalised recommendations